**Core Concept**
Hypernephroma, also known as renal cell carcinoma (RCC), is a type of cancer that originates in the lining of the proximal convoluted tubule, a part of the small tubes in the kidney that transport waste molecules from the blood to the urine. The underlying pharmacological and physiological principles being tested involve the characteristics and clinical presentation of RCC.

**Why the Correct Answer is Right**
Since the correct answer is not provided, let's discuss the general characteristics of hypernephroma. RCC is the most common type of kidney cancer in adults, and it is known for its variable presentation, including a classic triad of symptoms: hematuria, flank pain, and abdominal mass. The tumor can produce various substances, leading to paraneoplastic syndromes.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific details of option A, it's challenging to provide a precise explanation. However, common incorrect statements about hypernephroma might include misconceptions about its origin, symptoms, or treatment options.
**Option B:** Similarly, without the details of option B, it's difficult to address why it might be incorrect. Typically, incorrect options might involve confusion with other types of kidney diseases or cancers.
**Option C:** Again, lacking the specifics of option C, a common mistake could involve the prognosis or common sites of metastasis for hypernephroma.
**Option D:** This option might be incorrect due to misinformation about the risk factors, genetic predisposition, or diagnostic approaches for hypernephroma.

**Clinical Pearl / High-Yield Fact**
A critical point to remember about renal cell carcinoma is its association with various paraneoplastic syndromes, such as hypertension, hypercalcemia, and erythrocytosis, due to the secretion of substances like renin, parathyroid hormone-related protein, and erythropoietin, respectively.

**Correct Answer:** Correct Answer: D.